AI-generated analysis. Always verify with the original filing.
Femasys Inc. entered into an Omnibus Amendment and Consent Agreement on March 19, 2026, with Consenting Holders to remove the Share Combination Event Adjustment from Senior Secured Convertible Notes and Warrants effective December 31, 2025, issuing Series D-1 Warrants exercisable at $0.58 for 16,378,563 shares. Joshua Silverman resigned as director on March 17, 2026; Kenneth D. Eichenbaum was appointed on March 18, 2026.
Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. As previously announced, pursuant to the Securities Purchase Agreement dated as of November 3, 2025, by and among
. The aggregate 16,378,563 Series D-1 Warrants are being issued by the Company in reliance upon the exemption from the registration requirements of the Securiti
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On March 17, 2
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 4.1 Form of Series D-1 Warrant 10.1 Omnibus Amendment and Consent Agreement, dated as o
Joshua Silverman
Effective: 2026-03-17
not due to any dispute or disagreement with the Company on operations, policies or practices
Kenneth D. Eichenbaum, M.D., M.S.E.
Effective: 2026-03-18
pursuant to board nomination right granted to Pointillist Global Macro Series of Pointillist Partners LLC (Lead Lender) under Securities Purchase Agreement
Material Agreement